GREAT POINT PARTNERS LLC Q3 2023 significant ownership

Add to watchlist

GREAT POINT PARTNERS LLC is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.

13F

13D/G

GREAT POINT PARTNERS LLC Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
89bio, Inc.	February 14, 2023	700,000	1.4%
KalVista Pharmaceuticals, Inc.	February 14, 2023	1,055,801	3.1%
Avalo Therapeutics, Inc.	February 13, 2023	974,639	7.1%
InflaRx N.V.^{Sold out}	February 14, 2022	0	0.0%
ABEONA THERAPEUTICS INC.^{Sold out}	February 16, 2021	0	0.0%
CONSTELLATION PHARMACEUTICALS INC	February 16, 2021	1,024,800	2.2%
GERON CORP	February 16, 2021	12,754,228	4.0%
Millendo Therapeutics, Inc.	February 16, 2021	270,000	1.4%
NextCure, Inc.^{Sold out}	February 16, 2021	0	0.0%
PROTHENA CORP PUBLIC LTD CO	February 16, 2021	977,647	2.4%
TG THERAPEUTICS, INC.^{Sold out}	February 16, 2021	0	0.0%
VYNE Therapeutics Inc.^{Sold out}	February 16, 2021	0	0.0%
Zymeworks Inc.	February 16, 2021	799,722	1.8%
Audentes Therapeutics, Inc.^{Sold out}	February 14, 2020	0	0.0%
BIOCRYST PHARMACEUTICALS INC^{Sold out}	February 14, 2020	0	0.0%
CYTOKINETICS INC	February 14, 2020	160,073	0.3%
FIVE PRIME THERAPEUTICS, INC.^{Sold out}	February 14, 2020	0	0.0%
Foamix Pharmaceuticals Ltd.^{Sold out}	February 14, 2020	0	0.0%
Kura Oncology, Inc.	February 14, 2020	853,777	1.9%
Menlo Therapeutics Inc.	February 14, 2020	1,652,013	6.8%
PROTEOSTASIS THERAPEUTICS, INC.^{Sold out}	February 14, 2020	0	0.0%
Savara Inc^{Sold out}	February 14, 2020	0	0.0%
STREAMLINE HEALTH SOLUTIONS INC.^{Sold out}	February 14, 2020	0	0.0%
ZAFGEN, INC.^{Sold out}	February 14, 2020	0	0.0%
ZOGENIX, INC.	February 14, 2020	670,000	1.5%
PUMA BIOTECHNOLOGY, INC.	May 14, 2019	1,096,626	2.8%
NEWLINK GENETICS CORP^{Sold out}	February 14, 2019	0	0.0%
Protagonist Therapeutics, Inc	February 14, 2019	955,618	4.0%
RIGEL PHARMACEUTICALS INC^{Sold out}	February 14, 2019	0	0.0%
CONNECTURE INC^{Sold out}	January 08, 2019	0	0.0%
ARADIGM CORP^{Sold out}	February 14, 2018	0	0.0%
ARENA PHARMACEUTICALS INC	February 14, 2018	1,177,119	3.0%
BOVIE MEDICAL Corp^{Sold out}	February 14, 2018	0	0.0%
CATALYST PHARMACEUTICALS, INC.	February 14, 2018	3,817,288	3.7%
CONCERT PHARMACEUTICALS, INC.	February 14, 2018	669,472	2.9%
Ignyta, Inc.^{Sold out}	February 14, 2018	0	0.0%
Ocera Therapeutics, Inc.^{Sold out}	February 14, 2018	0	0.0%
PTC THERAPEUTICS, INC.	February 14, 2018	1,085,800	2.6%
ROCKET PHARMACEUTICALS, INC.^{Sold out}	February 14, 2018	0	0.0%
SUNESIS PHARMACEUTICALS INC^{Sold out}	February 14, 2018	0	0.0%
TREVENA INC^{Sold out}	February 14, 2018	0	0.0%
Vanda Pharmaceuticals Inc.	February 14, 2018	797,531	1.8%
Adamas Pharmaceuticals Inc	October 10, 2017	256,340	1.1%
ARENA PHARMACEUTICALS INC	April 28, 2017	30,000,000	9.8%
ALCOBRA LTD.^{Sold out}	February 14, 2017	0	0.0%
ALIMERA SCIENCES INC	February 14, 2017	2,293,675	3.5%
Aurinia Pharmaceuticals Inc.^{Sold out}	February 14, 2017	0	0.0%
INOTEK PHARMACEUTICALS CORP	February 14, 2017	1,500,000	5.6%
TETRAPHASE PHARMACEUTICALS INC^{Sold out}	February 14, 2017	0	0.0%
Vericel Corp^{Sold out}	February 14, 2017	0	0.0%
Biodel Inc^{Sold out}	February 16, 2016	0	0.0%
CombiMatrix Corp^{Sold out}	February 16, 2016	0	0.0%
DISCOVERY LABORATORIES INC /DE/	February 16, 2016	280,952	3.4%
ONCOGENEX PHARMACEUTICALS, INC.^{Sold out}	February 16, 2016	0	0.0%
PALATIN TECHNOLOGIES INC	February 16, 2016	2,337,000	3.3%
STRATA Skin Sciences, Inc.^{Sold out}	February 16, 2016	0	0.0%
SUNESIS PHARMACEUTICALS INC	February 16, 2016	8,512,385	10.0%
SYNERGY PHARMACEUTICALS, INC.	February 16, 2016	1,546,888	1.4%
Synthetic Biologics, Inc.	February 16, 2016	3,589,400	3.8%
DISCOVERY LABORATORIES INC /DE/	July 28, 2015	6,496,251	6.1%
Anthera Pharmaceuticals Inc	February 17, 2015	250,000	1.1%
AVEO PHARMACEUTICALS INC^{Sold out}	February 17, 2015	0	0.0%
CombiMatrix Corp	February 17, 2015	970,874	8.1%
MELA SCIENCES, INC. /NY	February 17, 2015	670,058	10.0%
PAIN THERAPEUTICS INC^{Sold out}	February 17, 2015	0	0.0%
Recro Pharma, Inc.^{Sold out}	February 17, 2015	0	0.0%
SOPHIRIS BIO INC.^{Sold out}	February 17, 2015	0	0.0%
Sunshine Heart, Inc.^{Sold out}	February 17, 2015	0	0.0%
TENAX THERAPEUTICS, INC.^{Sold out}	February 17, 2015	0	0.0%
WaferGen Bio-systems, Inc.	February 17, 2015	132,456	2.2%
AASTROM BIOSCIENCES INC	September 22, 2014	2,170,000	10.0%
AMBIT BIOSCIENCES CORP	July 07, 2014	1,053,895	5.9%
OXYGEN BIOTHERAPEUTICS, INC.	March 28, 2014	2,000,000	7.2%
Furiex Pharmaceuticals, Inc.	February 14, 2014	319,536	3.1%
Mast Therapeutics, Inc.	February 14, 2014	4,194,934	4.0%
WaferGen Bio-systems, Inc.	February 14, 2014	994,741	10.0%
ARADIGM CORP	February 06, 2014	40,322,580	6.9%
BOVIE MEDICAL CORP	December 23, 2013	1,947,747	10.0%
STEMLINE THERAPEUTICS INC	May 28, 2013	620,627	5.0%
AMICUS THERAPEUTICS INC	February 14, 2013	482,001	1.0%
OREXIGEN THERAPEUTICS INC^{Sold out}	February 14, 2013	0	0.0%
TENGION INC^{Sold out}	February 14, 2013	0	0.0%
VENTRUS BIOSCIENCES INC^{Sold out}	February 14, 2013	0	0.0%
ZOGENIX, INC.	February 14, 2013	3,697,900	3.6%
BIODELIVERY SCIENCES INTERNATIONAL INC^{Sold out}	February 14, 2012	0	0.0%
BIOSANTE PHARMACEUTICALS INC	February 14, 2012	882,353	0.8%
DYNAVAX TECHNOLOGIES CORP	February 14, 2012	4,750,000	3.7%
EPICEPT CORP	February 14, 2012	3,181,818	4.3%
SOLTA MEDICAL INC	February 14, 2012	1,485,149	2.4%
TENGION INC	February 14, 2012	1,901,603	7.6%
Biodel Inc	May 31, 2011	3,827,375	9.9%
AASTROM BIOSCIENCES INC	February 14, 2011	2,222,222	7.3%
AMARIN CORP PLC	February 14, 2011	1,150,000	1.1%
ANADYS PHARMACEUTICALS INC	February 14, 2011	3,455,000	6.0%
Marina Biotech, Inc.^{Sold out}	February 14, 2011	0	0.0%
NeuroMetrix, Inc.	February 14, 2011	1,569,321	6.4%
THRESHOLD PHARMACEUTICALS INC	February 14, 2011	837,695	2.4%
Transition Therapeutics Inc.^{Sold out}	February 14, 2011	0	0.0%
ZIOPHARM ONCOLOGY INC	February 14, 2011	806,500	1.6%
InfuSystem Holdings, Inc	February 11, 2011	?	?
AEOLUS PHARMACEUTICALS, INC.	February 16, 2010	1,302,747	2.7%
Altus Pharmaceuticals Inc.^{Sold out}	February 18, 2009	0	0.0%
CYPRESS BIOSCIENCE INC	February 18, 2009	150,000	0.4%
FIRST CONSULTING GROUP INC^{Sold out}	February 18, 2009	0	0.0%
FIVE STAR QUALITY CARE INC	February 18, 2009	198,720	0.6%
KERYX BIOPHARMACEUTICALS INC	February 18, 2009	15,000	0.0%
NEUROBIOLOGICAL TECHNOLOGIES INC /CA/	February 18, 2009	217,391	0.8%
NOVAMED INC	February 18, 2009	904,908	3.8%
RENOVIS INC^{Sold out}	February 18, 2009	0	0.0%
ABIOMED INC	February 17, 2009	1,714,935	4.8%
AMAG PHARMACEUTICALS INC.	February 17, 2009	137,550	0.8%
ARQULE INC^{Sold out}	February 17, 2009	0	0.0%
AVALON PHARMACEUTICALS INC	February 17, 2009	960,000	4.6%
INSPIRE PHARMACEUTICALS INC	February 17, 2009	500,000	0.9%
KOSAN BIOSCIENCES INC^{Sold out}	February 17, 2009	0	0.0%
MEDecision, Inc.^{Sold out}	February 17, 2009	0	0.0%
NPS PHARMACEUTICALS INC^{Sold out}	February 17, 2009	0	0.0%
ON ASSIGNMENT INC^{Sold out}	February 17, 2009	0	0.0%
REPROS THERAPEUTICS INC.^{Sold out}	February 17, 2009	0	0.0%
MEMORY PHARMACEUTICALS CORP	January 09, 2009	?	?
ADOLOR CORP	February 14, 2008	1,520,000	3.3%
AP PHARMA INC /DE/	February 14, 2008	?	?
DUSA PHARMACEUTICALS INC	February 14, 2008	1,150,000	4.8%
REPROS THERAPEUTICS INC.	February 14, 2008	850,000	6.6%
CAPRIUS INC	December 17, 2007	6,594,000	63.5%
SGX PHARMACEUTICALS, INC.	December 03, 2007	1,542,264	7.4%
HAPC, Inc.	October 25, 2007	3,000,000	16.1%
KERYX BIOPHARMACEUTICALS INC	August 06, 2007	2,375,400	5.4%
AP PHARMA INC /DE/	February 14, 2007	1,863,107	7.4%
Chelsea Therapeutics International, Ltd.	February 14, 2007	1,138,176	5.8%
DOV PHARMACEUTICAL INC^{Sold out}	February 14, 2007	0	0.0%
IDERA PHARMACEUTICALS, INC.	February 14, 2007	193,874	1.0%
PANACOS PHARMACEUTICALS, INC.	February 14, 2007	2,180,015	4.3%
GENTA INC DE/	February 14, 2006	3,460,666	3.0%
ZONAGEN INC	February 14, 2006	721,100	7.2%
RIGEL PHARMACEUTICALS INC	December 15, 2005	1,900,000	7.9%
PANACOS PHARMACEUTICALS, INC.	August 31, 2005	3,972,547	9.4%
ADVANCED MAGNETICS INC	June 09, 2005	1,685,652	16.6%
NEOPROBE CORP	December 23, 2004	16,500,000	22.7%

Compare quarters

Export GREAT POINT PARTNERS LLC's holdings